US EditionEmbattled TAVR Device Myval Meets Expectations in Trial, but Trouble Still Ahead
Summary by MedPage Today
2 Articles
2 Articles
All
Left
Center
1
Right
MedPage TodayReposted by 
Anti-Aging, Acupuncture and Health News
Anti-Aging, Acupuncture and Health NewsEmbattled TAVR Device Myval Meets Expectations in Trial, but Trouble Still Ahead
(MedPage Today) -- For a balloon-expandable transcatheter aortic valve replacement (TAVR or TAVI) platform, the much-litigated Myval performed well enough in the COMPARE-TAVI 1 randomized trial, but its rates of pacemakers and paravalvular leaks...
·New York, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage